Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 9 Dec 2024
- Closes
- 2 Nov 2026, 23:59 UTC
- Reference
- PAR-24-280
- Location
- United States
- Sector
- Healthcare & Pharma
Details
This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
CFDA number(s): 93.846
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 208 notices from National Institutes of Health, going back to May 2023 — 190 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 210 open Healthcare & Pharma tenders in United States. This one closes in 47 days.
More from this buyer
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)· closes 12 Mar
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)· closes 4 Oct
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)· closes 2 Jul
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)· closes 7 May
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)· closes 7 Sept
Similar Healthcare & Pharma tenders
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Introducer Kit, Cathete — 2 each, NSN· closes 22 Sept
- Residential Reentry Center Located Within the City limits of Raleigh, North Carolina. Home Confinement Radius is Within 200 miles of the Facility· closes 15 Oct
- Philadelphia VA Medical Center Radiopharmacueticals — Drugs and Biologicals· closes 21 Sept
- Spectacles, Industrial — 233 each, NSN· closes 28 Sept
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- National IC, LGU Circular Economy Diagnostics Iloilo-Guimaras and Davao-Samal)UNDP · Philippines
- National IC, LGU Circular Economy Diagnostics (RDC8 and Siargao)UNDP · Philippines
- Request for Proposal for Selection of Agency for Exchange of Surplus PlasmaAll India Institute of Medical Sciences-Patna · eProcurement Cell - AIIMS Patna · India
- 四川大学华西口腔医院2026年临床研究建设项目第九批采购项目招标公告四川大学华西口腔医院 · China
- 四川大学华西医院流式分析分选仪等采购项目公开招标采购公告四川大学华西医院 · China
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →